Why Aclaris Therapeutics Stock Skyrocketed More Than 200% Today
Investors are excited about the biotech's clinical trial results.
Aclaris Therapeutics
ACRS
ACRS
$20.67
-$0.35
-1.7%
Price as of February 24, 2021, 9:00 p.m. EST
View Interactive ACRS Charts
ACLARIS THERAPEUTICS INC
Interactive Chart
News & Analysis: Aclaris Therapeutics
Here's Why Aclaris Therapeutics Stock Collapsed Today
A mid-stage trial failure has investors questioning the company's approach.
Aclaris Therapeutics, Inc. (ACRS) Q1 2019 Earnings Call Transcript
ACRS earnings call for the period ending March 31, 2019.
Aclaris Therapeutics, Inc. (ACRS) Q4 2018 Earnings Conference Call Transcript
ACRS earnings call for the period ending December 31, 2018.
Aclaris Therapeutics (ACRS) Q4 2017 Earnings Conference Call Transcript
ACRS earnings call for the period ending December 31, 2017.
Could These 2 Biotech Stocks Really Double Your Money?
Analyst price targets for these two biotechs suggest they could double your money. Here's what you need to know.
Why Aclaris Therapeutics, Inc. Stock Is Down Today
The pharma's shares dipped on a $65 million capital raise.
The Best IPOs of 2015
2015 was not a particularly strong year for IPOs, but these five did quite well.
